Locanabio, Inc. Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Locanabio is a biotechnology company developing genetic medicines intended to correct the messages produced by disease-causing RNA. Its platform uses gene therapy to deliver RNA-binding modalities that can selectively modulate disease-associated RNA through multiple mechanisms without altering a cell’s DNA. The aim is a durable, single-administration therapy with programs focused on rare genetic neuromuscular and neurodegenerative diseases across various tissues. The company is based in San Diego, California, and operates with a small, science-oriented team within the biotechnology research sector. In October 2023, it announced the launch of a vectorized RNA-targeting platform and presented supporting preclinical data.